Skip to the page

Data / Medical devices / China / Wuxi Biohermes Bio & Medical Technology Co., Ltd.

Wuxi Biohermes Bio & Medical Technology Co., Ltd.: FDA-registered device maker in Wuxi Jiangsu, China, 1 510(k) clearance

Wuxi Biohermes Bio & Medical Technology Co., Ltd. is registered with the FDA (registration 3012526002) in Wuxi Jiangsu, China. It lists 3 device types. The FDA files 1 510(k) clearance under its listings, the newest dated June 16, 2017. Registered through 2026. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
3012526002
Address
No.136 Mashan Meiliang Road,Binhu, Wuxi Jiangsu, China, 214092
Owner or operator
Wuxi Biohermes Bio & Medical Technology Co., Ltd. (10051365)
Roles
Manufacturer
First device listed
March 7, 2016
Registered through
2026
Brand names listed
BioHermes, A1C EZ Glycohemoglobin Analysis System, model A1C EZ 2, Insulin-like Growth Factor Binding Protein-1 Test Kit(Colloidal Gold)

Devices it lists

510(k) clearances

The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.

Decided510(k) numberDeviceProduct codeDecisionApplicantSource
June 16, 2017K161533A1C EZ Glycohemoglobin Analysis SystemLCPSubstantially EquivalentBiohermes Co., Ltd.accessdata.fda.gov

Compare with other makers

Updated June 16, 2017. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.